Plasma immunoreactive beta-endorphin levels in depression. Effect of electroconvulsive therapy

Arch Gen Psychiatry. 1983 Feb;40(2):181-3. doi: 10.1001/archpsyc.1983.01790020079007.

Abstract

Immunoreactive (ir) plasma beta-endorphin level was assayed in ten symptomatic patients with a unipolar major depressive disorder and in 16 psychiatrically normal controls matched for age and sex. Plasma ir-beta-endorphin level in depressed patients was similar to that in controls. All depressed patients was similar to that in controls. All depressed patients had a transient, approximately threefold increase in ir-beta-endorphin after each use of electroconvulsive therapy (ECT). The increase of plasma ir-beta-endorphin level after ECT parallels the transient elevation of adrenocorticotropic hormone level reported by others and probably reflects a hypothalamic response to ECT.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenocorticotropic Hormone / blood
  • Adult
  • Aged
  • Depressive Disorder / blood*
  • Depressive Disorder / physiopathology
  • Depressive Disorder / therapy
  • Electroconvulsive Therapy*
  • Endorphins / blood*
  • Endorphins / physiology
  • Female
  • Humans
  • Hypothalamus / physiopathology
  • Male
  • Middle Aged
  • Radioimmunoassay
  • beta-Endorphin

Substances

  • Endorphins
  • beta-Endorphin
  • Adrenocorticotropic Hormone